GIST
Primary Site | Histology | Behavior | Year of Diagnosis |
---|---|---|---|
C000-C529, C571-C699, C739-C750, C754-C809 | 8935-8936 | <Any value> | <Any value> |
C530-C539 | 8935-8936 | <Any value> | 2018-2020 |
C700-C729, C751-C753 | 8935-8936 | 3 | <Any value> |
Notes
8935-8936 (C000-C529, C571-C809; C530-C539 for 2018-2020)
Note 1: The following sources were used in the development of this schema
- SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
- SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
- Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
- Chapter 43 Gastrointestinal Stromal Tumor, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
Note 2: GIST of the cervix, corpus, ovary and fallopian tube are collected in the following:
- C530-C539 for 2021 and later: Cervix Sarcoma
- C540-C549, C559: Corpus Sarcoma
- C569: Ovary
- C570: Fallopian Tube
Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | Yes |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
Schema Discriminator 1 | <BLANK> | Yes |
NAACCR #3926
schemaDiscriminator1 |
All | SSDI |
Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
Tumor Size Summary | 999 | Yes |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
LVI | 8 | No |
NAACCR #1182
lymphVascularInvasion |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
Grade Post Therapy Clin (yc) | <BLANK> | Yes |
NAACCR #1068
gradePostTherapyClin |
All | SSDI |
Grade Post Therapy Path (yp) | <BLANK> | Yes |
NAACCR #3845
gradePostTherapy |
All | SSDI |
KIT Gene Immunohistochemistry | 8 | No |
NAACCR #3865
kitGeneImmunohistochemistry |
CCCR/Canada COC SEER (RC) |
SSDI |